GMP-certified medical cannabis manufacturer and distributor in Germany
Cansativa manufactures and distributes medical cannabis across Germany with GMP and GDP certifications. The company is investing heavily in production efficiency—lean process improvement, equipment commissioning, and compliance monitoring are all active—while simultaneously scaling backend operations (HR digitalization, IT security). The hiring mix reflects this dual push: manufacturing and ops roles dominate, but HR and software implementation projects signal infrastructure maturation beyond pure supply-chain execution.
Cansativa is a pharmaceutical manufacturer and distributor licensed for medical cannabis production, import, and trade in Germany. Founded in 2017, the company operates distribution and fulfillment centers in Frankfurt and Mörfelden-Walldorf, supplying pharmacies and pharmaceutical wholesalers nationwide. The business is built on GMP and GDP compliance, recently securing manufacturing authorization for both sites. Cansativa positions itself as a first-mover focused on standardizing the medical cannabis supply chain, reducing patient costs, and destigmatizing the market. The company uses enterprise software (SAP, Salesforce, HubSpot, Power BI) alongside Microsoft 365 infrastructure, with ongoing investment in IT security and software rollouts.
Cansativa runs on SAP for ERP, Salesforce and HubSpot for CRM/marketing, Power BI for analytics, and Microsoft 365 (Teams, SharePoint, Exchange) plus Azure for cloud infrastructure and identity management.
Yes, Cansativa has 10 active roles focused on manufacturing (3), operations (3), and executive/support functions (4), with steady hiring velocity across mid- and junior-level positions.
Active projects include lean production process improvement, equipment commissioning, GMP compliance optimization, HR digitalization, IT security initiatives, and marketing ecosystem build for its cannabis brands.
Other companies in the same industry, closest in size